BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19633468)

  • 21. Vitamin K and oral anticoagulation: thought for food.
    Bovill EG; Fung M; Cushman M
    Am J Med; 2004 May; 116(10):711-3. PubMed ID: 15121498
    [No Abstract]   [Full Text] [Related]  

  • 22. Novel anticoagulants and the future of anticoagulation.
    Garcia D
    Thromb Res; 2009; 123 Suppl 4():S50-5. PubMed ID: 19303505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should I follow a special diet while taking warfarin?
    Mayo Clin Womens Healthsource; 2005 Dec; 9(12):10. PubMed ID: 16301990
    [No Abstract]   [Full Text] [Related]  

  • 24. Warfarin: effects on anticoagulant, hematologic, and blood enzyme values in normal ponies.
    Scott EA; Sandler GA; Byars TD
    Am J Vet Res; 1979 Jan; 40(1):142-6. PubMed ID: 453677
    [No Abstract]   [Full Text] [Related]  

  • 25. [Vitamin K in food and the effect of warfarin].
    Melien Ø; Johansen PW; Westergren T; Rugstad HE
    Tidsskr Nor Laegeforen; 2003 Jun; 123(13-14):1862-3. PubMed ID: 12830268
    [No Abstract]   [Full Text] [Related]  

  • 26. Guidelines on oral anticoagulation (warfarin): third edition--2005 update.
    Baglin TP; Keeling DM; Watson HG;
    Br J Haematol; 2006 Feb; 132(3):277-85. PubMed ID: 16409292
    [No Abstract]   [Full Text] [Related]  

  • 27. Warfarin therapy. 2.
    Deykin D
    N Engl J Med; 1970 Oct; 283(15):801-3. PubMed ID: 4917271
    [No Abstract]   [Full Text] [Related]  

  • 28. Use of thromboelastography to demonstrate persistent anticoagulation after stopping enoxaparin.
    Simons R; Mallett SV
    Anaesthesia; 2007 Nov; 62(11):1175-8. PubMed ID: 17924901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A practical approach to minimize the interaction of dietary vitamin K with warfarin.
    Chang CH; Wang YW; Yeh Liu PY; Kao Yang YH
    J Clin Pharm Ther; 2014 Feb; 39(1):56-60. PubMed ID: 24383939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous and oral sulodexide versus coagulation activation markers in humans.
    Borawski J; Dubowski M; Rydzewska-Rosolowska A; Mysliwiec M
    Clin Appl Thromb Hemost; 2009 Oct; 15(5):596-8. PubMed ID: 19910295
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety indicators for inpatient and outpatient oral anticoagulant care: [corrected] Recommendations from the British Committee for Standards in Haematology and National Patient Safety Agency.
    Baglin TP; Cousins D; Keeling DM; Perry DJ; Watson HG
    Br J Haematol; 2007 Jan; 136(1):26-9. PubMed ID: 17116128
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of two synthetic anticoagulant drugs (coumarin and inandione) in the ewe.
    Morag M; Smith DR
    Res Vet Sci; 1971 Mar; 12(2):106-12. PubMed ID: 5572531
    [No Abstract]   [Full Text] [Related]  

  • 34. Warfarin-acetaminophen interaction.
    Med Lett Drugs Ther; 2008 Jun; 50(1288):45. PubMed ID: 18551088
    [No Abstract]   [Full Text] [Related]  

  • 35. Determinants of the response to oral anticoagulant drugs in man.
    O'Reilly RA; Aggeler PM
    Pharmacol Rev; 1970 Mar; 22(1):35-96. PubMed ID: 4918964
    [No Abstract]   [Full Text] [Related]  

  • 36. Novel oral anticoagulants and diet: the potential for interaction.
    Kamali F
    Am J Hematol; 2009 Apr; 84(4):260-1. PubMed ID: 19253346
    [No Abstract]   [Full Text] [Related]  

  • 37. Comment: Decreased warfarin effect after initiation of high-protein, low-carbohydrate diets.
    Kalvass JC; Phinney SD; Vernon MC; Rosedale R; Westman EC
    Ann Pharmacother; 2005; 39(7-8):1371-2; author reply 1372. PubMed ID: 15928257
    [No Abstract]   [Full Text] [Related]  

  • 38. Efficacy of intravenous vitamin K in a case of massive warfarin overdosage.
    Kitchens CS
    Thromb Haemost; 2001 Aug; 86(2):719-20. PubMed ID: 11522034
    [No Abstract]   [Full Text] [Related]  

  • 39. [Changes brought about in blood coagulation in the newborn by administration of vitamin K2. 3. Clinical application of vitamin K2 after exchange transfusion (author's transl)].
    Suzuki S
    Z Kinderheilkd; 1973 Oct; 115(3):261-6. PubMed ID: 4770089
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antivitamin K. Introduction].
    Larcan A
    Angeiologie; 1967; 19(5):33-5. PubMed ID: 5621970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.